1. Introduction {#sec1}
===============

Substance abuse during pregnancy is associated with considerable obstetrical morbidity and mortality. Its prevalence is largely unknown, although the USA 2013 National Survey on Drug Use and Health estimated it on 5,4% \[[@B1]\]. An increased risk of spontaneous abortion, preterm delivery, placental abnormalities, hypertensive complications, fetal growth restriction (FGR), low birth weight infants, neonatal abstinence syndrome, sudden infant death syndrome, and long term behavioral effects have all been associated with antenatal substance use \[[@B2]--[@B7]\]. However, little attention has been drawn to their effect on the mechanism of labor and delivery. In vitro studies have proved that opioids and cannabinoids exert uterorelaxant action whereas cocaine augments contractility in human myometrium \[[@B8]--[@B12]\]. Nevertheless, the clinical correlation of these findings has never been studied.

Our aim was to evaluate the mode of delivery and the factors that influence it in drug-dependent pregnant women.

2. Material and Methods {#sec2}
=======================

We conducted a retrospective study of drug-dependent (DD) pregnant women whose antenatal care and delivery took place at the Department of Obstetrics B of Centro Hospitalar e Universitário de Coimbra, a tertiary-care university hospital, between January 2001 and December 2014. Because the study involved completely deidentified data extraction from electronic patient records, patient consent was not required. The study was conducted according to the Declaration of Helsinki and regional authority requirements.

A total of 269 DD patients delivered in our institution during the study period. We excluded 33 women (12,3%) because they were Human Immunodeficiency Virus- (HIV-) positive (*n* = 19), had missing outcome data (*n* = 5), fetal malformations (*n* = 2), multiple pregnancy (*n* = 6), and Rh isoimmunization (one case). None of the patients reviewed presented chronic medical comorbidities other than psychiatric and/or infectious. A total of 236 DD patients were enrolled in our study. Controls were non-drug-dependent (non-DD) healthy women, randomly selected from our institutional administrative records, with a delivery date during the study period (*n* = 228).

DD patients\' antenatal care was based on a multidisciplinary model involving a program of care between hospital services and drug agencies working with drug users. Antenatal care is available on a regular basis at the local drug dependency unit as well as within our institution. The control group had a model of care shared between primary care and hospital specialist services.

The patients\' records were reviewed and the following data were registered:

2.1. Maternal Characteristics {#sec2.1}
-----------------------------

The woman\'s age, educational level, ethnicity, and body mass index (BMI) were recorded. BMI was calculated upon maternal self-report of height and prepregnancy weight. Educational level was considered high if high school or higher education had been completed.

Regarding obstetric history, gravity, parity, previous cesarean section or vaginal delivery, previous abortion, and trimester of first antenatal visit were also registered.

2.2. Pregnancy and Neonatal Outcomes {#sec2.2}
------------------------------------

Pregnancy complications associated with drug dependence including hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, and eclampsia), placental abnormalities (placenta previa and abruptio placentae), and FGR were registered. The definitions of gestational hypertension, preeclampsia, and eclampsia were those adopted by the International Society for the Study of Hypertension in Pregnancy \[[@B13]\]. FGR was defined as estimated birth weight \<10th centile. Delivery data included gestational age at delivery, fetal presentation at delivery, labor induction, and mode of delivery. Newborn birth weight and 5-minute Apgar score were also recorded.

2.3. DD Group Characteristics {#sec2.3}
-----------------------------

A woman was considered a drug user if she had self-reported use of substitution maintenance treatment, heroin, cocaine, or cannabinoids at any time during pregnancy. Urine drug testing was performed only as an adjunct to detect or confirm suspected substance abuse after obtaining patient consent. Nonactive consumption was defined as drug withdrawal at any time during pregnancy. Data regarding the type of drug abused (opioids, cannabinoids, and cocaine), the route of administration (intravenous, smoked, and mixed), opioid replacement therapy (methadone, buprenorphine, and naloxone), associated addictions (smoking and alcohol history during the index pregnancy), and infectious diseases (HIV, Hepatitis C, Hepatitis B, and Syphilis) were recorded. HIV-positive women were excluded due to the fact that elective cesarean section was performed in all patients until 2014.

G^*∗*^Power software v. 3.1.3. was used to calculate the sample size. The mode of delivery was the endpoint used in power analysis calculation. For a power of 80% and *α* = 0.05, the sample size should be *n*1 = 368 and *n*2 = 123. After applying the exclusion criteria, we obtained a sample size of *n*1 = 355 and *n*2 = 109, with a power of 0.784 for *α* = 0.05. We accepted these values for our study.

Categorical variables were compared using the *χ*^2^ test or Fisher\'s exact test, according to the Cochran rules. Continuous variables were tested for normal distribution (Kolmogorov-Smirnov test). Those following a normal distribution were compared using the independent samples Student *t*-test and the independent samples Mann--Whitney *U* test was conducted to compare those that did not follow a normal distribution. Factors influencing the mode of delivery were determined using logistic regression analysis. All statistical analysis was performed using SPSS v. 23.0 (IBM Corp.). *p* values \< 0.05 were considered statistically significant.

The following steps were taken to determine if drug dependency influenced the mode of delivery and the factors that influenced the mode of delivery in DD patients: the factors that predicted the mode of delivery in the study population were determined. Binary logistic regression was performed to analyze the independent influence of drug dependency in the mode of the delivery. Finally, the factors that influenced the mode of delivery within the DD group were analyzed.

3. Results {#sec3}
==========

Maternal characteristics and pregnancy and labor details were compared with a low risk control-population of non-DD patients ([Table 1](#tab1){ref-type="table"}). Drug-dependent patients were younger (28.40 ± 5.84 versus 29.51 ± 4.81 years, *p* = 0.021) and presented a lower BMI (21.89 ± 3.73 Kg/m^2^ versus 24.16 ± 4.27 Kg/m^2^, *p* \< 0.001). The rate of nulliparity was also lower in this group (46.2% versus 64.5%, *p* \< 0.001), with a higher rate of previous vaginal delivery (83.5% versus 72.8%, *p* = 0.041) despite no difference in the previous cesarean section rate. The incidence of FGR was 20.3%, significantly higher than in the control group (*p* \< 0.001). Preterm delivery was also more frequent amongst drug-using women, complicating 16.6% of births (*p* \< 0.001). The incidence of low birth weight was 25.8% amongst DD women compared to 13.6% in control women (*p* = 0.001). Of note is the extremely low incidence of placental abnormalities (0.8%) and hypertensive complications (3%) in the DD group.

Regarding the mode of delivery during the study period, the DD group presented a significantly lower rate of cesarean section (18.2% versus 28.9%, *p* = 0.006).

The factors that influenced the mode of delivery (vaginal delivery versus cesarean section) in the study sample were determined ([Table 2](#tab2){ref-type="table"}). Maternal age (*p* = 0.038), nulliparity (*p* = 0.017), previous cesarean section (*p* \< 0.001) or vaginal delivery (*p* \< 0.001), drug dependence (*p* = 0.006), placental abnormalities (*p* = 0.001), and fetal presentation at delivery (*p* \< 0.001) were significantly associated with the mode of delivery.

In order to analyze the individual effect of each of these factors on the mode of delivery, binary logistic regression analysis was conducted and demonstrated that significant independent contributions were provided by drug dependence, previous cesarean section, previous vaginal delivery, and fetal presentation (resp., *β* = 0.567, 95% CI = 0.328--0.980; *β* = 6.279, 95% CI = 3.092--12.753; *β* = 0.167, 95% CI = 0.075--0.374; and *β* = 54.689, 95% CI = 18.150--164.792; *R*^2^ = 0.416; *p* \< 0.001). Among DD women, the risk of cesarean section was approximately one-half the risk among the control population.

DD group characteristics are displayed in [Table 3](#tab3){ref-type="table"}. A total of 161 women (68.2%) presented active consumption at the time of delivery. Opioids were the most common drugs reported (89.4%). Within the 75.8% of patients under substitution maintenance therapy, methadone was the most frequent (66.1%).

Finally, the factors that influenced the mode of delivery within the DD group were determined ([Table 4](#tab4){ref-type="table"}). No difference was found regarding the pattern of consumption. Curiously, there was no difference in relation to the mode of delivery between women with active consumption at delivery and those who stopped consumption at any time during pregnancy.

4. Discussion {#sec4}
=============

Previous studies have focused on the influence of drug abuse on maternal and neonatal morbidity and mortality as well as on the impact of substitution maintenance therapy on these outcomes.

In view of the fact that in vitro studies have shown the influence of the analyzed drugs in myometrial function \[[@B8]--[@B12]\], we undertook this study to analyze the factors that influence the mode of delivery in DD pregnant women. Our results demonstrate that the DD population presented a lower rate of cesarean section. Curiously, the state of consumption, type of drug, route of administration, and substitution maintenance therapy did not contribute to this difference. This may be partially attributable to sample size as the subgroups may lack the statistical power to exclude such differences. Also, their lower BMI, obstetric history, delayed prenatal care, higher rate of coaddictions and infectious diseases, and the higher incidence of prematurity and low birth weight did not seem to influence the route of delivery.

Limitations to this study are mainly related to the fact that the study design cannot remove all potential biases and our findings might be explained by the variety of confounders presented by the study population. In particular, DD pregnant women are more likely to have a lower socioeconomical status and suffer the psychological impact of family instability and high-risk behaviors, such as prostitution and violence. These factors, associated with negative feelings about pregnancy or an unintended or unwanted pregnancy, may contribute to delayed medical care during labor, with patients attending the hospital at a more advanced stage of labor. Therefore, we hypothesize that psychological factors may explain the difference in the route of delivery in DD pregnant women demonstrated in this study.

Further research is needed to elucidate the underlying psychosocial reasons for the higher rate of vaginal delivery found in our study.
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###### 

Maternal characteristics and pregnancy and neonatal outcomes of the study groups.

  ----------------------------------------------------------------------------------------------------------
                                  DD group\          Non-DD group\       Odds ratio (95% CI)     *p* value
                                  (*n* = 236)        (*n* = 228)                                 
  ------------------------------- ------------------ ------------------- ----------------------- -----------
  *Maternal characteristics*                                                                      

  Maternal age (years)            28.40 (5.84)       29.51 (4.81)                                0.021

  Body mass index (Kg/m^2^)       21.89 (3.73)       24.16 (4.27)                                \<0.001

  Ethnicity                                                              1.463 (0.458--4.679)    0.519

   Caucasian                      231 (97.9)         221 (96.9)                                   

  Educational level                                                      0.130 (0.084--0.202)    \<0.001

   Low                            170 (77.6)         60 (31.1)                                    

  Nulliparous                     109 (46.2)         147 (64.5)          0.473 (0.326--0.687)    \<0.001

  Within multiparous                                                                              

   Previous cesarean section      22 (17.3)          22 (27.2)           0.562 (0.287--1.100)    0.090

   Previous vaginal delivery      106 (83.5)         59 (72.8)           2.002 (1.022--3.922)    0.041

  *Pregnancy complications*                                                                       

  Placental abnormalities         2 (0.8)            3 (1.8)             0.641 (0.106--3.872)    0.625

  Hypertensive complications      7 (3.0)            5 (2.2)             1.363 (0.426--4.359)    0.600

  Fetal growth restriction        48 (20.3)          6 (2.6)             9.447 (3.955--22.563)   \<0.001

  *Labor and neonatal outcomes*                                                                   

  Gestational age (weeks)         37.97 (1.53)       38.83 (31.20)                               \<0.001

  Prematurity (\<37 weeks)        39 (16.6)          9 (3.9)             4.842 (2.287--10.250)   \<0.001

   32^+0^--36^+6^ weeks           35 (14.9)          9 (3.9)             4.258 (1.997--9.080)    \<0.001

   28^+0^--31^+6^ weeks           4 (1.7)            0                   0.503 (0.460--0.551)    0.124

  Fetal presentation                                                     0,963 (0.496--1.870)    0.912

   Cephalic                       217 (91.9)         209 (91.7)                                   

   Noncephalic                    19 (8.1)           19 (8.3)                                     

  Induction of labor              58 (24.9)          60 (26.3)           0.928 (0.611--1.410)    0.726

  Cesarean section                43 (18.2)          66 (28.9)           0.547 (0.353--0.847)    0.006

  Newborn birth weight (g)        2812.23 (456.59)   3180.47 (2812.23)                           \<0.001

   \<2500 g                       61 (25.8)          31 (13.6)           2.215 (1.374--3.572)    0.001

   \<1500 g                       4 (1.7)            0                   0.504 (0.460--0.552)    0.124

  5 min Apgar score \<7           2 (0.8)            0                   0.506 (0.463--0.554)    0.499
  ----------------------------------------------------------------------------------------------------------

Values are mean (standard deviation) for continuous variables or *n* (%) for categorical variables.

###### 

Factors that influenced the mode of delivery in the study population.

  ----------------------------------------------------------------------------------------------------------
                               Vaginal delivery\   Cesarean section\   Odds ratio (95% CI)       *p* value
                               (*n* = 355)         (*n* = 109)                                   
  ---------------------------- ------------------- ------------------- ------------------------- -----------
  *Maternal characteristics*                                                                      

  Maternal age (years)         28.75 (5.08)        29.88 (5.22)                                  0.038

  Body mass index (Kg/m^2^)    22.45 (4.09)        23.86 (4.45)                                  0.055

  Ethnicity                                                            0.919 (0.244--3.456)      0.901

   Caucasian                   346 (97.5)          106 (97.2)                                     

   Non-Caucasian               9 (2.5)             3 (2.8)                                        

  Nulliparity                  185 (52.1)          71 (65.1)           1.717 (1.100--2.681)      0.017

  Previous cesarean section    18 (5.1)            26 (23.9)           5.865 (3.070--11.203)     \<0.001

  Previous vaginal delivery    153 (43.1)          12 (11.0)           0.163 (0.087--0.301)      \<0.001

  Drug dependence              193 (54.5)          43 (39.1)           0.547 (0.353--0.847)      0.006

  *Pregnancy complications*                                                                       

  Placental abnormalities      0                   5 (4.6)             0.227 (0.191--0.260)      0.001

  Hypertensive complications   10 (2.8)            2 (1.8)             0.645 (0.139--2.989)      0.572

  Fetal growth restriction     44 (12.4)           10 (12.2)           0.714 (0.397--1.471)      0.359

  *Labor characteristics*                                                                         

  Gestational age (weeks)      38.43 (1.41)        38.48 (1.47)                                  0.581

  Fetal presentation                                                   30.395 (11.491--80.400)   \<0.001

   Cephalic                    350 (98.6)          76 (69.7)                                      

   Noncephalic                 5 (1.4)             33 (30.3)                                      

  Induction of labor           95 (27.0)           23 (21.1)           0.724 (0.432--1.213)      0.218
  ----------------------------------------------------------------------------------------------------------

Values are mean (standard deviation) for continuous variables or *n* (%) for categorical variables.

###### 

Drug dependent group characteristics.

                                        *n* = 236
  ------------------------------------- ------------
  *Pattern of consumption*               
  Active consumption during pregnancy   161 (68.2)
  Type of drug                           
   Cocaine                              99 (41.9)
   Opioids                              211 (89.4)
   Cannabinoids                         69 (29.2)
   Mixed                                123 (52.1)
   Only opioids                         93 (39.4)
   Only cannabinoids                    16 (6.8)
   Only cocaine                         4 (1.7)
  Route of administration                
   Smoked                               113 (47.9)
   Intravenous                          41 (17.4)
   Mixed                                22 (9.3)
  *Substitution maintenance therapy*     
  Methadone                             156 (66.1)
  Buprenorphine                         18 (7.6)
  Naltrexone                            5 (2.1)
  None                                  57 (24.2)
  *Comorbidities*                        
  Psychiatric disease                   58 (24.6)
  Infectious diseases                    
   Hepatitis C                          118 (50)
   Hepatitis B                          6 (2.5)
   Syphilis                             6 (2.5)
  *Coaddictions*                         
  Smoking history                       180 (76.3)
  Alcohol abuse                         15 (6.4)

Values are *n* (%).

###### 

Factors that influence the mode of delivery in drug-dependent patients.

  ---------------------------------------------------------------------------------------------------------------
                                     Vaginal delivery\   Cesarean section\   Odds ratio (95% CI)      *p* value
                                     (*n* = 193)         (*n* = 43)                                   
  ---------------------------------- ------------------- ------------------- ------------------------ -----------
  *Maternal characteristics*                                                                           

  Maternal age (years)               28.13 (5.28)        29.39 (5.86)                                 0.297

  Body mass index (Kg/m^2^)          21.82 (3.85)        22.04 (3.28)                                 0.452

  Ethnicity                                                                  0.889 (0.097--8.157)     0.917

   Caucasian                         189 (97.9)          42 (97.7)                                     

   Non-Caucasian                     4 (2.1)             1 (2.3)                                       

  Nulliparous                        84 (43.5)           25 (58.1)           1.802 (0.923--3.520)     0.082

  Previous cesarean section          13 (6.7)            9 (20.9)            3.665 (1.453--9.248)     0.008

  Previous vaginal delivery          97 (50.3)           9 (20.9)            0.262 (0.119--0.576)     \<0.001

  *Pattern of consumption*                                                                             

  State of consumption                                                       0.646 (0.325--1.281)     0.209

   Active                            135 (70.3)          26 (60.5)                                     

   Nonactive                         57 (29.7)           17 (39.5)                                     

  Type of drug                                                                                         

   Only opioids                      71 (36.8)           22 (51.2)           1.800 (0.925--3.503)     0.081

   Only cocaine                      3 (1.6)             1 (2.3)             1.508 (0.153--14.857)    0.555

   Only cannabinoids                 15 (7.8)            1 (2.3)             0.283 (0.036--2.199)     0.317

   Mixed                             104 (53.9)          19 (44.2)           0.677 (0.348--1.317)     0.350

  Route of administration                                                                              

   Intravenous                       33 (17.2)           8 (18.6)            1.101 (0.469--2.589)     0.825

   Smoked                            91 (47.4)           22 (51.2)           1.163 (0.600--2.253)     0.655

   Mixed                             17 (77.3)           5 (22.7)            1.354 (0.471--3.898)     0.566

  Substitution maintenance therapy                                                                     

   Methadone                         128 (66.3)          28 (65.1)           0.948 (0.473--1.898)     0.880

   Buprenorphine                     13 (6.7)            5 (11.6)            1.822 (0.613--5.414)     0.336

   Naltrexone                        4 (2.1)             1 (2.3)             1.125 (0.123--10.324)    1.000

   None                              48 (24.9)           9 (20.9)            0.800 (0.358--1.787)     0.585

  *Infectious diseases*                                                                                

  Hepatitis C                        91 (47.2)           27 (62.8)           1.891 (0.958--3.733)     0.064

  Hepatitis B                        4 (2.1)             2 (4.7)             2.305 (0.408--13.009)    0.300

  Syphilis                           4 (2.1)             2 (4.7)             2.305 (0.408--13.009)    0.300

  *Associated addictions*                                                                              

  Smoking history                    148 (82.2)          32 (78)             0.769 (0.334--1.767)     0.535

  Alcohol use                        12 (6.8)            3 (7.5)             1,115 (0.299--4.150)     0.871

  *Pregnancy data*                                                                                     

  Delayed prenatal care              123 (63.7)          29 (67.4)           1.179 (0.584--2.379)     0.646

  Placental abnormalities            0                   2 (4.7)             0.175 (0.133--0.231)     0.033

  Hypertensive complications         5 (2.6)             2 (4.7)             1.834 (0.344--9.785)     0.614

  Fetal growth restriction           39 (20.2)           9 (20.9)            1.045 (0.463--2.360)     0.915

  *Labor characteristics*                                                                              

  Gestational age (weeks)            37.98 (1.56)        37.86 (1.73)                                 0.895

  Fetal presentation                                                         25.313 (7.839--81.734)   \<0.001

   Cephalic                          189 (97.9)          28 (65.1)                                     

   Noncephalic                       4 (2.1)             15 (34.9)                                     

  Induction of labor                 49 (25.8)           9 (20.9)            0.762 (0.341--1.701)     0.506

  Newborn birth weight (g)           2781.99 (508.96)    2719.30 (541.49)                             0.786
  ---------------------------------------------------------------------------------------------------------------

Values are mean (standard deviation) for continuous variables or *n* (%) for categorical variables.
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